Stock Events

Stock Events

HAVN Life Sciences 

€0.019000
28
+€0.00+0% Monday 20:00

Statistics

Day High
0.019
Day Low
0.019
52W High
0.019
52W Low
0.019
Volume
766
Avg. Volume
0
Mkt Cap
280,022
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-7,970.24%Profit Margin
Unprofitable
2019
2020
2021
202,451.43Revenue
-16.14MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 5NP0.MU. It's not an investment recommendation.
Compass Pathways
4
CMPS
Tesla
3
TSLA
Zim Integrated Shipping Services
3
ZIM
Revive Therapeutics
3
RVVTF

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap1.84B
Compass Pathways operates in the psychedelic medicine space, focusing on psilocybin therapy for depression, directly competing with HAVN's research and development in psychedelic compounds.
AtaiBeckley
ATAI
Mkt Cap1.9B
ATAI Life Sciences is a biotech company with a focus on psychedelic and non-psychedelic compounds for mental health disorders, overlapping with HAVN's mission.
GH Research
GHRS
Mkt Cap1.82B
GH Research PLC is involved in the development of therapeutic solutions using psychedelic substances, which aligns with HAVN's focus areas.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness Inc. is engaged in psychedelic therapy research and development, offering services that compete with HAVN's offerings.
Revive Therapeutics
RVVTF
Mkt Cap9.15M
Revive Therapeutics focuses on the research and development of psychedelics for medical use, including treatments for mental health disorders.
TripAdvisor
TRIP
Mkt Cap1.63B
Red Light Holland Corp. is involved in the production, growth, and sale of a premium brand of magic truffles, competing in the psychedelics market.
Noveris Health Sciences
MYCOF
Mkt Cap64.4M
Mydecine Innovations Group Inc. specializes in the development and production of adaptive pathway medicines, including psychedelics, which puts them in competition with HAVN Life Sciences.

About

HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is headquartered in Richmond, Canada.
Show more...
CEO
ISIN
CA4196213058

Listings

MU
DE
5NP.MU
STU
DE
5NP0.STU
MU
DE
5NP0.MU
CN
CA
HAVN.CN

0 Comments

Share your thoughts

FAQ

What is HAVN Life Sciences stock price today?▼
The current price of 5NP0.MU is €0.02 EUR — it has increased by +0% in the past 24 hours. Watch HAVN Life Sciences stock price performance more closely on the chart.
What is HAVN Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange HAVN Life Sciences stocks are traded under the ticker 5NP0.MU.
What is HAVN Life Sciences market cap?▼
Today HAVN Life Sciences has the market capitalization of 280,022
What is HAVN Life Sciences revenue for the last year?▼
HAVN Life Sciences revenue for the last year amounts to 202,451.43 EUR.
What is HAVN Life Sciences net income for the last year?▼
5NP0.MU net income for the last year is -16.14M EUR.
In which sector is HAVN Life Sciences located?▼
HAVN Life Sciences operates in the Other sector.
When did HAVN Life Sciences complete a stock split?▼
The last stock split for HAVN Life Sciences was on August 03, 2022 with a ratio of 1:30.